CapsoVision (CV) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

CapsoVision

NasdaqCM•Healthcare•Medical Devices

$5.99+0.02(<0.01%)Market closed

Market Cap

$325.59M

P/S

19.5x

P/B

24.7x

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

How this company scores

WeakMetricSide Score: 36/100

Strongest: Balance Sheet & Red Flags (15/25); weakest: Profitability (5/25).

Profitability5/25

Growth10/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality6/25

Strengths

Interest easily coveredConsistent growthNet cash positionImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 19.5x5y range 19.5x – 20.8x

P/B · 24.7x5y range 16.8x – 45.9x

Currently near its 4-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 5 of the last 5 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $325.59M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $16.67M
Q. Revenue: $3.64M
TTM EBITDA: $-35.31M
TTM Op. Income: $-35.54M
Q. Op. Income: $-7.58M
TTM Net Income: $-35.20M
Q. Net Income: $-7.48M
EPS: $-0.15
Shares Out.: $49.94M

$16.67M in TTM revenue grew from zero YoY, reaching $3.64M last quarter. TTM EBITDA of $-35.31M and TTM operating income of $-35.54M show growth is flowing through to the bottom line. However, net income is negative at $35.20M — growth is not yet reaching the bottom line. Across the last 5 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 51.4%
EBITDA Margin: -206.5%
Op. Margin: -208.1%
Net Margin: -205.4%

Op. margin of -208.1% is down 67.8% YoY — costs are rising relative to revenue. Net margin at -205.4% and gross margin of 51.4% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 48% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 19.5x
P/B Ratio: 24.7x

P/S of 19.5x and P/B of 24.7x. P/S is high, meaning growth expectations are priced in.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $18.57M
Cash: $9.08M
Long-Term Debt: N/A
Book Value: $13.17M
D/E Ratio: N/A
Debt/EBITDA: N/A

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-8.40M
TTM Free Cash Flow: $-27.89M
FCF Margin: -167.3%
FCF / Net Income: 0.8

TTM FCF of $-27.89M on $-8.40M in operating cash flow. The FCF / Net Income ratio of 0.8x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 0% — an improving trend.